№5 (338) / 2017

Ya.V. Girsh, O.A. Veliyeva
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
8-13
N.A. Demidov (1), M.B. Antsiferov (2), L.G. Dorofeeva (2)
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
14-20
E.V. Biryukova
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
21-27
A.S. Ametov
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
28-35
E.V. Biryukova
MODERN OPPORTUNITIES OF BONE ANABOLIC THERAPY OF OSTEOPOROSIS
36-42
M.E. Telnova, N.A. Petunina
BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS. EFFICACY AND SAFETY OF IBANDRONATE
43-47
M.B. Antsiferov (1), V.S. Pronin (2)
STRATEGY OF ACTIVE SEARCH FOR PATIENTS WITH ACROMEGALY: CASE REPORT
48-50
I.B. Zhurtova
THE CHOICE OF TACTICS OF TREATMENT OF GIANT RETROSTERNAL DIFFUSE TOXIC GOITER IN ELDERLY AGE
51-55
I.T. Murkamilov (1), K.A. Aytbaev (2), F.A. Yusupov (3)
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
56-59
A.F. Verbovoy, L.A. Sharonova, A.V. Pashentseva, I.A. Tsanava
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
60-67
L.A. Sharonova, A.F. Verbovoy, I.A. Tsanava
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
68-74
N.A. Petunina, A.L. Terekhova
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
75-81
I.A. Baranova
ALFACALCIDOL IN TREATMENT OF OSTEOPOROSIS
82-85
N.A. Chernikova
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
86-90
A.F. Verbovoy, Yu.A. Dolgikh, O.V. Kosareva, L.A. Sharonova, I.A. Tsanava
INSULIN RESISTANCE AND THYROID HORMONES
91-95

Бионика Медиа